Antidepressant medication exposure: time to pregnancy and risk of pregnancy loss
Depression and antidepressant medication use is prevalent in women of reproductive age. Evidence is conflicting regarding antidepressant exposure and miscarriage risk. Therefore, using prospective data on pregnancy and loss from a cohort of women in the Effects of Aspirin in Gestation and Reproduction Trial, we assessed the association between preconception-measured antidepressant exposure and time to pregnancy, pregnancy loss, and live birth.
Source: fertstert.org
Antidepressant medication exposure: time to pregnancy and risk of pregnancy loss
Published in Embryology and Reproductive Medicine
More from Embryology and Reproductive MedicineMore posts in Embryology and Reproductive Medicine »
- Life after Stillbirth
- The possible impact of COVID 19 on fertility and ART
- Human embryonic stem cell–derived blastocyst-like spheroids resemble human trophectoderm during early implantation process
- What support is available for you in hospital if you lose your baby
- Estrogen receptor-α immunoreactivity predicts symptom severity and pain recurrence in deep endometriosis
Be First to Comment